Related Experiment Video

Updated: Aug 8, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Gene therapy using an adenovirus vector for apoptosis-related genes is a highly effective therapeutic modality for

Nobusada Shinoura1, Hirofumi Hamada

  • 1Department of Neurosurgery, Komagome Metropolitan Hospital, Tokyo, Japan. shinoura-k@komagome-hospital.bunkyo.tokyo.jp

Current Gene Therapy
|March 26, 2003
PubMed

Insights

Adenoviral vectors show promise for cancer gene therapy. Delivering apoptosis-related genes, beyond p53, via these vectors offers a new strategy for treating brain tumors like gliomas.

Area of Science:

  • Oncolytic virotherapy
  • Gene therapy
  • Molecular oncology

Background:

  • Adenoviral vectors are being investigated for cancer gene therapy.
  • Gene delivery using adenoviral vectors, including p53, shows therapeutic potential for various cancers.
  • Apoptosis induction is a key strategy in cancer treatment.

Purpose of the Study:

  • To review novel strategies for inducing apoptosis in glioma cells using adenoviral vectors.
  • To explore the efficacy of delivering various apoptosis-related genes via adenoviral vectors.
  • To assess the potential of non-p53 gene therapy for brain tumors.

Main Methods:

  • Review of preclinical studies and human clinical trials on adenoviral vectors for cancer gene therapy.
  • Analysis of studies involving adenoviral vectors carrying apoptosis-related genes (e.g., Fas ligand, caspase-3, Bcl-2).
  • Focus on gene delivery mechanisms and apoptosis induction pathways.

Main Results:

  • Adenoviral vectors have demonstrated safety and efficacy in preclinical and clinical cancer gene therapy studies.
  • Delivery of p53 via adenoviral vectors is a recognized therapeutic approach.
  • Various apoptosis-related genes, when delivered by adenoviral vectors, can induce apoptosis in glioma cells.

Conclusions:

  • Adenoviral vector-mediated gene therapy is a promising approach for cancer treatment.
  • Targeting apoptosis pathways with specific genes delivered by adenoviral vectors offers potential for glioma treatment.
  • Gene therapy using adenoviral vectors carrying apoptosis-related genes, excluding p53, represents a viable strategy for human brain tumors.

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Quantification of Adeno-Associated Viral Genomes in Purified Vector Samples by Digital Droplet Polymerase Chain Reaction04:43

Quantification of Adeno-Associated Viral Genomes in Purified Vector Samples by Digital Droplet Polymerase Chain Reaction

Published on: October 11, 2024

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...